Multicenter Study

. 2020 Mar;47(3):377-386.

doi: 10.3899/jrheum.181232. Epub 2019 May 15.

Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis

Maurizio Bruschi^{1

2}, Alice Bonanni^{1

2}, Andrea Petretto^{1

2}, Augusto Vaglio^{1

2}, Federico Pratesi^{1

2}, Laura Santucci^{1

2}, Paola Migliorini^{1

2}, Roberta Bertelli^{1

2}, Maricla Galetti^{1

2}, Silvana Belletti^{1

2}, Lorenzo Cavagna^{1

2}, Gabriella Moroni^{1

2}, Franco Franceschini^{1

2}, Micaela Fredi^{1

2}, Giulia Pazzola^{1

2}, Landino Allegri^{1

2}, Renato Alberto Sinico^{1

2}, Giampaola Pesce^{1

2}, Marcello Bagnasco^{1

2}, Angelo Manfredi^{1

2}, Giuseppe A Ramirez^{1

2}, Paola Ramoino^{1

2}, Paolo Bianchini^{1

2}, Francesco Puppo^{1

2}, Francesca Pupo^{1

2}, Simone Negrini^{1

2}, Federico Mattana^{1

2}, Giacomo Emmi^{1

2}, Giacomo Garibotto^{1

2}, Domenico Santoro^{1

2}, Francesco Scolari^{1

2}, Angelo Ravelli^{1

2}, Angela Tincani^{1

2}, Paolo Cravedi^{1

2}, Stefano Volpi^{1

2}, Giovanni Candiano^{1

2}, Gian Marco Ghiggeri^{3

4}

Affiliations

¹ From the Laboratory of Molecular Nephrology, Core Facilities-Proteomics Laboratory, Division of Paediatric Rheumatology and Division of Nephrology, Dialysis, and Transplantation, Scientific Institute for Research and Health Care (IRCCS) Istituto Giannina Gaslini, Genoa; Nephrology Unit, University Hospital, University of Parma; Clinical Immunology Unit, Department of Internal Medicine, University of Pisa; Italian Workers' Compensation Authority (INAIL) Research Center at the University of Parma, Italy; S.Bi.Bi.T Department of the University of Parma, Parma; Division of Rheumatology, University and IRCCS Policlinico S. Matteo, Pavia; Division of Nephrology and Dialysis, IRCCS, Regina Elena, Milan; Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia; Nephrology and Dialysis, Arciospedale Santa Maria Nuova, Reggio Emilia; Department of Medicine and Surgery, University of Milan, Bicocca; Medical and Radiometabolic Therapy Unit, Department of Internal Medicine, University of Genoa; Unit of Internal Medicine and Immunology, IRCCS Ospedale San Raffaele, Milan; Department of Earth, Environment and Life Sciences (DISTAV), University of Genoa; Department of Nanophysics, Italian Institute of Technology (IIT); Department of Internal Medicine, University of Genoa; Division of Nephrology, University of Genoa and Policlinico San Martino, Genoa; Lupus Clinic Department of Biomedicine, University of Florence, University Hospital Careggi, Florence; Nephrology and Dialysis Unit, University of Messina and G. Martino Hospital, Messina; Division of Nephrology and Dialysis, University of Brescia and Ospedale di Montichiari, Brescia, Italy; Nephrology Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
² M. Bruschi, PhD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; A. Bonanni, MD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; A. Petretto, PhD, Core Facilities-Proteomics Laboratory, IRCCS Istituto Giannina Gaslini; A. Vaglio, MD, Nephrology Unit, University Hospital, University of Parma; F. Pratesi, MD, Clinical Immunology Unit, Department of Internal Medicine, University of Pisa; L. Santucci, PhD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; P. Migliorini, MD, Clinical Immunology Unit, Department of Internal Medicine, University of Pisa; R. Bertelli, PhD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; M. Galetti, PhD, INAIL Research Center at the University of Parma; S. Belletti, MD, S.Bi.Bi.T Department of the University of Parma; L. Cavagna, MD, Division of Rheumatology, University and IRCCS Policlinico S. Matteo; G. Moroni, MD, Division of Nephrology and Dialysis, Fondazione IRCCS Ca' Granda Ospedale Maggiore Milano; F. Franceschini, MD, Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia; M. Fredi, MD, Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia; G. Pazzola, MD, Nephrology and Dialysis, Arciospedale Santa Maria Nuova; L. Allegri, MD, Nephrology Unit, University Hospital, University of Parma; R.A. Sinico, MD, Department of Medicine and Surgery, University of Milan; G. Pesce, PhD, Medical and Radiometabolic Therapy Unit, Department of Internal Medicine, University of Genoa; M. Bagnasco, MD, Medical and Radiometabolic Therapy Unit, Department of Internal Medicine, University of Genoa; A. Manfredi, MD, Unit of Internal Medicine and Immunology, IRCCS Ospedale San Raffaele; G.A. Ramirez, MD, Unit of Internal Medicine and Immunology, IRCCS Ospedale San Raffaele; P. Ramoino, MD, DISTAV, University of Genoa; P. Bianchini, MD, Department of Nanophysics, IIT; F. Puppo, MD, Department of Internal Medicine, University of Genoa; F. Pupo, MD, Department of Internal Medicine, University of Genoa; S. Negrini, MD, Department of Internal Medicine, University of Genoa; F. Mattana, MD, Division of Nephrology, University of Genoa and Policlinico San Martino; G. Emmi, MD, Lupus Clinic Department of Biomedicine, University of Florence, University Hospital Careggi; G. Garibotto, MD, Division of Nephrology, University of Genoa and Policlinico San Martino; D. Santoro, MD, Nephrology and Dialysis Unit, University of Messina and G. Martino Hospital; F. Scolari, MD, Division of Nephrology and Dialysis, University of Brescia and Ospedale di Montichiari; A. Ravelli, MD, Division of Paediatric Rheumatology, IRCCS Istituto Giannina Gaslini; A. Tincani, MD, Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia; P. Cravedi, MD, Nephrology Division, Department of Medicine, Icahn School of Medicine at Mount Sinai; S. Volpi, MD, Division of Paediatric Rheumatology, IRCCS Istituto Giannina Gaslini; G. Candiano, PhD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; G.M. Ghiggeri, MD, PhD, Laboratory of Molecular Nephrology, and Division of Nephrology, Dialysis, and Transplantation, IRCCS Istituto Giannina Gaslini.
³ From the Laboratory of Molecular Nephrology, Core Facilities-Proteomics Laboratory, Division of Paediatric Rheumatology and Division of Nephrology, Dialysis, and Transplantation, Scientific Institute for Research and Health Care (IRCCS) Istituto Giannina Gaslini, Genoa; Nephrology Unit, University Hospital, University of Parma; Clinical Immunology Unit, Department of Internal Medicine, University of Pisa; Italian Workers' Compensation Authority (INAIL) Research Center at the University of Parma, Italy; S.Bi.Bi.T Department of the University of Parma, Parma; Division of Rheumatology, University and IRCCS Policlinico S. Matteo, Pavia; Division of Nephrology and Dialysis, IRCCS, Regina Elena, Milan; Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia; Nephrology and Dialysis, Arciospedale Santa Maria Nuova, Reggio Emilia; Department of Medicine and Surgery, University of Milan, Bicocca; Medical and Radiometabolic Therapy Unit, Department of Internal Medicine, University of Genoa; Unit of Internal Medicine and Immunology, IRCCS Ospedale San Raffaele, Milan; Department of Earth, Environment and Life Sciences (DISTAV), University of Genoa; Department of Nanophysics, Italian Institute of Technology (IIT); Department of Internal Medicine, University of Genoa; Division of Nephrology, University of Genoa and Policlinico San Martino, Genoa; Lupus Clinic Department of Biomedicine, University of Florence, University Hospital Careggi, Florence; Nephrology and Dialysis Unit, University of Messina and G. Martino Hospital, Messina; Division of Nephrology and Dialysis, University of Brescia and Ospedale di Montichiari, Brescia, Italy; Nephrology Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA. GMarcoGhiggeri@ospedale-gaslini.ge.it.
⁴ M. Bruschi, PhD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; A. Bonanni, MD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; A. Petretto, PhD, Core Facilities-Proteomics Laboratory, IRCCS Istituto Giannina Gaslini; A. Vaglio, MD, Nephrology Unit, University Hospital, University of Parma; F. Pratesi, MD, Clinical Immunology Unit, Department of Internal Medicine, University of Pisa; L. Santucci, PhD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; P. Migliorini, MD, Clinical Immunology Unit, Department of Internal Medicine, University of Pisa; R. Bertelli, PhD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; M. Galetti, PhD, INAIL Research Center at the University of Parma; S. Belletti, MD, S.Bi.Bi.T Department of the University of Parma; L. Cavagna, MD, Division of Rheumatology, University and IRCCS Policlinico S. Matteo; G. Moroni, MD, Division of Nephrology and Dialysis, Fondazione IRCCS Ca' Granda Ospedale Maggiore Milano; F. Franceschini, MD, Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia; M. Fredi, MD, Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia; G. Pazzola, MD, Nephrology and Dialysis, Arciospedale Santa Maria Nuova; L. Allegri, MD, Nephrology Unit, University Hospital, University of Parma; R.A. Sinico, MD, Department of Medicine and Surgery, University of Milan; G. Pesce, PhD, Medical and Radiometabolic Therapy Unit, Department of Internal Medicine, University of Genoa; M. Bagnasco, MD, Medical and Radiometabolic Therapy Unit, Department of Internal Medicine, University of Genoa; A. Manfredi, MD, Unit of Internal Medicine and Immunology, IRCCS Ospedale San Raffaele; G.A. Ramirez, MD, Unit of Internal Medicine and Immunology, IRCCS Ospedale San Raffaele; P. Ramoino, MD, DISTAV, University of Genoa; P. Bianchini, MD, Department of Nanophysics, IIT; F. Puppo, MD, Department of Internal Medicine, University of Genoa; F. Pupo, MD, Department of Internal Medicine, University of Genoa; S. Negrini, MD, Department of Internal Medicine, University of Genoa; F. Mattana, MD, Division of Nephrology, University of Genoa and Policlinico San Martino; G. Emmi, MD, Lupus Clinic Department of Biomedicine, University of Florence, University Hospital Careggi; G. Garibotto, MD, Division of Nephrology, University of Genoa and Policlinico San Martino; D. Santoro, MD, Nephrology and Dialysis Unit, University of Messina and G. Martino Hospital; F. Scolari, MD, Division of Nephrology and Dialysis, University of Brescia and Ospedale di Montichiari; A. Ravelli, MD, Division of Paediatric Rheumatology, IRCCS Istituto Giannina Gaslini; A. Tincani, MD, Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia; P. Cravedi, MD, Nephrology Division, Department of Medicine, Icahn School of Medicine at Mount Sinai; S. Volpi, MD, Division of Paediatric Rheumatology, IRCCS Istituto Giannina Gaslini; G. Candiano, PhD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; G.M. Ghiggeri, MD, PhD, Laboratory of Molecular Nephrology, and Division of Nephrology, Dialysis, and Transplantation, IRCCS Istituto Giannina Gaslini. GMarcoGhiggeri@ospedale-gaslini.ge.it.

PMID: 31092713
PMCID: PMC6917988
DOI: 10.3899/jrheum.181232

Multicenter Study

Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis

Maurizio Bruschi et al. J Rheumatol. 2020 Mar.

. 2020 Mar;47(3):377-386.

doi: 10.3899/jrheum.181232. Epub 2019 May 15.

Authors

Affiliations

¹ From the Laboratory of Molecular Nephrology, Core Facilities-Proteomics Laboratory, Division of Paediatric Rheumatology and Division of Nephrology, Dialysis, and Transplantation, Scientific Institute for Research and Health Care (IRCCS) Istituto Giannina Gaslini, Genoa; Nephrology Unit, University Hospital, University of Parma; Clinical Immunology Unit, Department of Internal Medicine, University of Pisa; Italian Workers' Compensation Authority (INAIL) Research Center at the University of Parma, Italy; S.Bi.Bi.T Department of the University of Parma, Parma; Division of Rheumatology, University and IRCCS Policlinico S. Matteo, Pavia; Division of Nephrology and Dialysis, IRCCS, Regina Elena, Milan; Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia; Nephrology and Dialysis, Arciospedale Santa Maria Nuova, Reggio Emilia; Department of Medicine and Surgery, University of Milan, Bicocca; Medical and Radiometabolic Therapy Unit, Department of Internal Medicine, University of Genoa; Unit of Internal Medicine and Immunology, IRCCS Ospedale San Raffaele, Milan; Department of Earth, Environment and Life Sciences (DISTAV), University of Genoa; Department of Nanophysics, Italian Institute of Technology (IIT); Department of Internal Medicine, University of Genoa; Division of Nephrology, University of Genoa and Policlinico San Martino, Genoa; Lupus Clinic Department of Biomedicine, University of Florence, University Hospital Careggi, Florence; Nephrology and Dialysis Unit, University of Messina and G. Martino Hospital, Messina; Division of Nephrology and Dialysis, University of Brescia and Ospedale di Montichiari, Brescia, Italy; Nephrology Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
² M. Bruschi, PhD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; A. Bonanni, MD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; A. Petretto, PhD, Core Facilities-Proteomics Laboratory, IRCCS Istituto Giannina Gaslini; A. Vaglio, MD, Nephrology Unit, University Hospital, University of Parma; F. Pratesi, MD, Clinical Immunology Unit, Department of Internal Medicine, University of Pisa; L. Santucci, PhD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; P. Migliorini, MD, Clinical Immunology Unit, Department of Internal Medicine, University of Pisa; R. Bertelli, PhD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; M. Galetti, PhD, INAIL Research Center at the University of Parma; S. Belletti, MD, S.Bi.Bi.T Department of the University of Parma; L. Cavagna, MD, Division of Rheumatology, University and IRCCS Policlinico S. Matteo; G. Moroni, MD, Division of Nephrology and Dialysis, Fondazione IRCCS Ca' Granda Ospedale Maggiore Milano; F. Franceschini, MD, Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia; M. Fredi, MD, Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia; G. Pazzola, MD, Nephrology and Dialysis, Arciospedale Santa Maria Nuova; L. Allegri, MD, Nephrology Unit, University Hospital, University of Parma; R.A. Sinico, MD, Department of Medicine and Surgery, University of Milan; G. Pesce, PhD, Medical and Radiometabolic Therapy Unit, Department of Internal Medicine, University of Genoa; M. Bagnasco, MD, Medical and Radiometabolic Therapy Unit, Department of Internal Medicine, University of Genoa; A. Manfredi, MD, Unit of Internal Medicine and Immunology, IRCCS Ospedale San Raffaele; G.A. Ramirez, MD, Unit of Internal Medicine and Immunology, IRCCS Ospedale San Raffaele; P. Ramoino, MD, DISTAV, University of Genoa; P. Bianchini, MD, Department of Nanophysics, IIT; F. Puppo, MD, Department of Internal Medicine, University of Genoa; F. Pupo, MD, Department of Internal Medicine, University of Genoa; S. Negrini, MD, Department of Internal Medicine, University of Genoa; F. Mattana, MD, Division of Nephrology, University of Genoa and Policlinico San Martino; G. Emmi, MD, Lupus Clinic Department of Biomedicine, University of Florence, University Hospital Careggi; G. Garibotto, MD, Division of Nephrology, University of Genoa and Policlinico San Martino; D. Santoro, MD, Nephrology and Dialysis Unit, University of Messina and G. Martino Hospital; F. Scolari, MD, Division of Nephrology and Dialysis, University of Brescia and Ospedale di Montichiari; A. Ravelli, MD, Division of Paediatric Rheumatology, IRCCS Istituto Giannina Gaslini; A. Tincani, MD, Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia; P. Cravedi, MD, Nephrology Division, Department of Medicine, Icahn School of Medicine at Mount Sinai; S. Volpi, MD, Division of Paediatric Rheumatology, IRCCS Istituto Giannina Gaslini; G. Candiano, PhD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; G.M. Ghiggeri, MD, PhD, Laboratory of Molecular Nephrology, and Division of Nephrology, Dialysis, and Transplantation, IRCCS Istituto Giannina Gaslini.
³ From the Laboratory of Molecular Nephrology, Core Facilities-Proteomics Laboratory, Division of Paediatric Rheumatology and Division of Nephrology, Dialysis, and Transplantation, Scientific Institute for Research and Health Care (IRCCS) Istituto Giannina Gaslini, Genoa; Nephrology Unit, University Hospital, University of Parma; Clinical Immunology Unit, Department of Internal Medicine, University of Pisa; Italian Workers' Compensation Authority (INAIL) Research Center at the University of Parma, Italy; S.Bi.Bi.T Department of the University of Parma, Parma; Division of Rheumatology, University and IRCCS Policlinico S. Matteo, Pavia; Division of Nephrology and Dialysis, IRCCS, Regina Elena, Milan; Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia; Nephrology and Dialysis, Arciospedale Santa Maria Nuova, Reggio Emilia; Department of Medicine and Surgery, University of Milan, Bicocca; Medical and Radiometabolic Therapy Unit, Department of Internal Medicine, University of Genoa; Unit of Internal Medicine and Immunology, IRCCS Ospedale San Raffaele, Milan; Department of Earth, Environment and Life Sciences (DISTAV), University of Genoa; Department of Nanophysics, Italian Institute of Technology (IIT); Department of Internal Medicine, University of Genoa; Division of Nephrology, University of Genoa and Policlinico San Martino, Genoa; Lupus Clinic Department of Biomedicine, University of Florence, University Hospital Careggi, Florence; Nephrology and Dialysis Unit, University of Messina and G. Martino Hospital, Messina; Division of Nephrology and Dialysis, University of Brescia and Ospedale di Montichiari, Brescia, Italy; Nephrology Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA. GMarcoGhiggeri@ospedale-gaslini.ge.it.
⁴ M. Bruschi, PhD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; A. Bonanni, MD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; A. Petretto, PhD, Core Facilities-Proteomics Laboratory, IRCCS Istituto Giannina Gaslini; A. Vaglio, MD, Nephrology Unit, University Hospital, University of Parma; F. Pratesi, MD, Clinical Immunology Unit, Department of Internal Medicine, University of Pisa; L. Santucci, PhD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; P. Migliorini, MD, Clinical Immunology Unit, Department of Internal Medicine, University of Pisa; R. Bertelli, PhD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; M. Galetti, PhD, INAIL Research Center at the University of Parma; S. Belletti, MD, S.Bi.Bi.T Department of the University of Parma; L. Cavagna, MD, Division of Rheumatology, University and IRCCS Policlinico S. Matteo; G. Moroni, MD, Division of Nephrology and Dialysis, Fondazione IRCCS Ca' Granda Ospedale Maggiore Milano; F. Franceschini, MD, Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia; M. Fredi, MD, Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia; G. Pazzola, MD, Nephrology and Dialysis, Arciospedale Santa Maria Nuova; L. Allegri, MD, Nephrology Unit, University Hospital, University of Parma; R.A. Sinico, MD, Department of Medicine and Surgery, University of Milan; G. Pesce, PhD, Medical and Radiometabolic Therapy Unit, Department of Internal Medicine, University of Genoa; M. Bagnasco, MD, Medical and Radiometabolic Therapy Unit, Department of Internal Medicine, University of Genoa; A. Manfredi, MD, Unit of Internal Medicine and Immunology, IRCCS Ospedale San Raffaele; G.A. Ramirez, MD, Unit of Internal Medicine and Immunology, IRCCS Ospedale San Raffaele; P. Ramoino, MD, DISTAV, University of Genoa; P. Bianchini, MD, Department of Nanophysics, IIT; F. Puppo, MD, Department of Internal Medicine, University of Genoa; F. Pupo, MD, Department of Internal Medicine, University of Genoa; S. Negrini, MD, Department of Internal Medicine, University of Genoa; F. Mattana, MD, Division of Nephrology, University of Genoa and Policlinico San Martino; G. Emmi, MD, Lupus Clinic Department of Biomedicine, University of Florence, University Hospital Careggi; G. Garibotto, MD, Division of Nephrology, University of Genoa and Policlinico San Martino; D. Santoro, MD, Nephrology and Dialysis Unit, University of Messina and G. Martino Hospital; F. Scolari, MD, Division of Nephrology and Dialysis, University of Brescia and Ospedale di Montichiari; A. Ravelli, MD, Division of Paediatric Rheumatology, IRCCS Istituto Giannina Gaslini; A. Tincani, MD, Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia; P. Cravedi, MD, Nephrology Division, Department of Medicine, Icahn School of Medicine at Mount Sinai; S. Volpi, MD, Division of Paediatric Rheumatology, IRCCS Istituto Giannina Gaslini; G. Candiano, PhD, Laboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini; G.M. Ghiggeri, MD, PhD, Laboratory of Molecular Nephrology, and Division of Nephrology, Dialysis, and Transplantation, IRCCS Istituto Giannina Gaslini. GMarcoGhiggeri@ospedale-gaslini.ge.it.

PMID: 31092713
PMCID: PMC6917988
DOI: 10.3899/jrheum.181232

Abstract

Objective: Neutrophil extracellular traps (NET) expose modified antigens for autoantibodies in vasculitis. Little is known about levels and removal pathways of NET in systemic lupus erythematosus (SLE), especially in lupus nephritis (LN). We determined circulating levels and defined NET removal in large subsets of patients with incident SLE (iSLE), some of whom had new-onset nephritis.

Methods: Serum levels of NET (ELISA), DNase1/DNase1L3 (ELISA), and DNase activity (functional assay) were determined in 216 patients with iSLE [103 had incident LN (iLN)], in 50 patients with other primary glomerulonephritis, and in healthy controls. Ex vivo NET production by neutrophils purified from a random selection of patients was quantified as elastase/DNA release and by immunofluorescence techniques.

Results: Serum NET levels were very high in iSLE/iLN compared to all groups of controls and correlated with anti-dsDNA, C3-C4, and proteinuria; iLN had the highest levels. DNase activity was decreased in iLN compared to SLE (20% had one-half DNase activity) despite similar serum levels of DNase1/DNase1L3. In these cases, pretreatment of serum with protein A restored DNase efficiency; 1 patient was homozygous for a c.289_290delAC variant of DNASE1L3. Ex vivo NET production by neutrophils purified from LN, SLE, and normal controls was similar in all cases.

Conclusion: Patients with iLN have increased circulating NET and reduced DNase activity, the latter being explained by the presence of inhibitory substances in circulation and/or by rare DNase1L3 mutations. Accumulation of NET derives from a multifactorial mechanism, and is associated and may contribute to disease severity in SLE, in particular to renal lesions. (Clinical trial registration: The Zeus study was registered at ClinicalTrials.gov, study number NCT02403115).

Keywords: DNASE ACTIVITY; DNASE LEVEL; DNASE MUTATIONS; NEUTROPHIL EXTRACELLULAR TRAPS.

PubMed Disclaimer

Conflict of interest statement

Competing interests. Authors declare no conflicts of interest. A patent on the use of anti-enolase antibodies in diagnosis of LN is pending.

Figures

**Figure 1.. Circulating Neutrophil Extracellular Traps (NETs) Remnants.**
(A) Serum NETs were determined using an ELISA measuring the DNA-MPO complex. Results are Relative Unit/ml given as median and interquartile range. The dotted line indicates the upper limit of normality (0.89). Here, it is reported serum NETs in all SLE, in all LN and in normal people. It is also, in parallel, shown NETs levels in LN patients split in the two subgroups divided according to the indications given in Materials and Methods (i.e. LN as onset, LN after 1year from the SLE onset). (B) ROC curves showing specificity and sensitivity of the DNA-MPO assay for LN and SLE patients.

**Figure 2.. Serum DNase activity.**
(A) DNase activity was determined with a one-step assay based on fluorescence decrease of degrading Picogreen DNA dye/double-stranded DNA (dsDNA). In patients indicated with a square serum DNase activity was re-tested after treatment with Protein A/G. The triangle indicates a boy who presented a c.289_290delAC homozygous variant in *DNASE1L3.* Here, it is also in parallel reported DNase activity in LN patients split in the two subgroups divided according to the indications given in Materials and Methods (i.e. LN as onset, LN after 1year from the SLE onset). (B) patients with LN were subdivided according to their serum levels of NETs remnants (higher and lower than the normal level of 0.5 RU/ml). (C) DNase activity in patients with high and low NETs remnants. All patients with DNase activity < 30% were patients in the high NETs group.

**Figure 3.. DNASE1 and DNASE1L3 levels.**
(A) DNASE1 serum levels. A homemade ELISA assay has been utilized to test DNASE1. Results are expressed as ng/ml and represented as median and interquartile range. (B) DNASE1L3 serum levels. For DNASE1L3 we utilized a commercial ELISA (LSBio kit, Seattle, USA). Results expressed as ng/ml are given as median and interquartile range. In this case, those LN patients who presented maximal variability in DNase activity were chosen for testing DNASE1L3 levels here including patients with low and patients with high DNase activity. For the broad distribution of values, ROC and normal limits were not calculated.

**Figure 4.. NETs production and protein composition.**
(A) *Ex vivo* NETs formation was evaluated as elastase and DNA release by resting neutrophils purified from patients with SLE (n=5), lupus nephritis (n=9) and from healthy controls (n=8). More cells (15 SLE, 18 LN and 27 controls) were utilized for stimulation with phorbol-12-myristate-13-acetate (PMA). Kinetics of NETs formation was analyzed in all supernatants utilizing the elastase method(13). (B) In all experiments the release of elastase from stimulated neutrophils was highly correlated with the release of DNA.

See this image and copyright information in PMC

References

1. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science 2004;303:1532–5. - PubMed
1. Nathan C Neutrophils and immunity: Challenges and opportunities. Nat Rev Immunol 2006;6:173–82. - PubMed
1. Papayannopoulos V, Zychlinsky A. Nets: A new strategy for using old weapons. Trends Immunol 2009;30:513–21. - PubMed
1. Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007;176:231–41. - PMC - PubMed
1. Urban C, Zychlinsky A. Netting bacteria in sepsis. Nat Med 2007;13:403–4. - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

Associated data

Actions
- Search in PubMed
- Search in ClinicalTrials.gov

Grants and funding

R01 AI132949/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis

Affiliations

Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

References

Publication types

MeSH terms

Substances

Associated data

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous